giiant pharma inc.

Giiant is a preclinical-stage biotech company, with its proprietary Precision Delivery technology platform, designs gut-restricted, tissue-specific, small molecule, drug therapeutics with various biological targets in gastroenterology. Its lead program GT-2108 is a microbiota-activated PDE4 inhibitor prodrugs, with improved drug tolerability and enhanced therapeutic effect.

Website

http://www.giiant.com

External link for giiant pharma inc.

Industry

Biotechnology Research

Company size

2-10 employees

Headquarters

Montreal, Quebec

Type

Privately Held

Founded

2014